Evidence map›Paper›PMID 40051558›Full record

ReviewFrontiers in pharmacology2025

Effect of hypoalbuminemia on drug pharmacokinetics.

Ilona Idasiak-Piechocka, Dominik Lewandowski, Wojciech Świgut, Jan Kalinowski, Klaudia Mikosza, Piotr Suchowiejski, Edyta Szałek, Agnieszka Karbownik, Miłosz Miedziaszczyk

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Review
  2. International journal of molecular sciences · 2026
    Observational
  3. HBV/HCV coinfection and anti-tuberculosis drug-induced liver injury: from risk assessment and exploration of mechanisms to preventive considerations.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  4. Pharmacokinetics in the Fontan circulation: a multi-organ puzzle.European heart journal. Cardiovascular pharmacotherapy · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ilona Idasiak-PiechockaDepartment of General and Transplant Surgery, Poznan University of Medical Sciences, Poznan, Poland.
Dominik LewandowskiThe Student Scientific Society of Poznan University of Medical Sciences, Poznan, Poland.
Wojciech ŚwigutThe Student Scientific Society of Poznan University of Medical Sciences, Poznan, Poland.
Jan KalinowskiThe Student Scientific Society of Poznan University of Medical Sciences, Poznan, Poland.
Klaudia MikoszaThe Student Scientific Society of Poznan University of Medical Sciences, Poznan, Poland.
Piotr SuchowiejskiThe Student Scientific Society of Poznan University of Medical Sciences, Poznan, Poland.
Edyta SzałekDepartment of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, Poznan, Poland.
Agnieszka KarbownikDepartment of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, Poznan, Poland.
Miłosz MiedziaszczykDepartment of General and Transplant Surgery, Poznan University of Medical Sciences, Poznan, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypoalbuminemia, defined as serum albumin levels below 35 g/L, is common in patients with conditions such as nephrotic syndrome, cirrhosis, or sepsis. This review examines the impact of hypoalbuminemia on the pharmacokinetics of selected drugs-such as antibiotics, immunosuppressants, antifungals, or anticonvulsants-emphasizing its role in drug efficacy and safety. Albumin is the main drug transporter and key binding protein, which influences the free drug concentration and drug activity. The review includes all studies available in the scientific literature found in the PubMed, Scopus, and Cochrane databases. The paper emphasizes the importance of therapeutic drug monitoring (TDM) in patients with hypoalbuminemia to avoid subtherapeutic or toxic drug levels. Many drugs need for dose adjustments to achieve therapeutic levels, especially in critically ill patients. The results of studies emphasize the need for individualized dosing regimens based on TDM to optimize drug therapy in patients with hypoalbuminemia. Our review is the first article to summarize the influence of hypoalbuminemia on the pharmacokinetic parameters of drugs and may be a useful tool for clinicians in their daily work.

Indexed as

distributiondrug pharmacokineticshypoalbuminemianephrotic syndromeprotein binding

Identifiers

PMID40051558
PMCPMC11882431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.